Ocular Therapeutix, Inc
OCULNasdaqCIK 1393434HealthcareFiscal year ends Dec 31
Reports and events: 230 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1620:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-116617 |
| 2026-08-0311:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-089450 |
| 2026-08-0311:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-089443 |
| 2026-06-1220:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-073496 |
| 2026-05-0511:28 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-055256 |
| 2026-05-0511:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-055241 |
| 2026-04-3021:17 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001104659-26-053176 |
| 2026-02-2721:02 ET | 8-K | 7.01 Regulation FD disclosure | 0001104659-26-021541 |
| 2026-02-0512:58 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-010664 |
| 2026-02-0512:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-010633 |
| 2026-01-2312:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-006015 |
| 2025-12-1821:30 ET | 8-K | 8.01 Other events | 0001104659-25-122564 |
| 2025-12-0522:17 ET | 8-K | 8.01 Other events | 0001104659-25-118940 |
| 2025-11-0412:25 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-105919 |
| 2025-11-0412:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-105914 |
| 2025-09-3012:21 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-094758 |
| 2025-09-3010:32 ET | 8-K | 8.01 Other events | 0001104659-25-094724 |
| 2025-08-0511:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010177 |
| 2025-08-0511:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-073909 |
| 2025-06-1120:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-058525 |
| 2025-05-0511:47 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006225 |
| 2025-05-0511:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-044349 |
| 2025-04-2921:00 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0001558370-25-005868 |
| 2025-03-0312:19 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-002000 |
| 2025-03-0312:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-019462 |
| 2025-02-1412:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-013473 |
| 2024-11-1412:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015613 |
| 2024-11-1412:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-118284 |
| 2024-10-0920:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-107348 |
| 2024-09-0312:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-096021 |
| 2024-08-0711:23 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011202 |
| 2024-08-0711:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-086535 |
| 2024-06-1413:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-071530 |
| 2024-06-0313:15 ET | 8-K | 2.05 Exit or disposal costs | 0001104659-24-067544 |
| 2024-05-0720:20 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007065 |
| 2024-05-0720:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-058003 |
| 2024-04-2920:10 ET | DEF 14A | Proxy statementPeriod 2024-06-12 | 0001558370-24-006110 |
| 2024-04-1820:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-048850 |
| 2024-03-2921:11 ET | 8-K | 8.01 Other events | 0001104659-24-041224 |
| 2024-03-1120:12 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-002902 |
| 2024-03-1120:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-032974 |
| 2024-02-2721:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-009774 |
| 2024-02-2212:34 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-026324 |
| 2024-01-2513:04 ET | 8-K | 8.01 Other events | 0001104659-24-006490 |
| 2023-12-1821:52 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-23-058175 |
| 2023-12-1413:46 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-125888 |
| 2023-11-0721:06 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-017989 |
| 2023-11-0721:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-115223 |
| 2023-10-0413:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-106651 |
| 2023-10-0320:15 ET | 8-K | 8.01 Other events | 0001104659-23-106399 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.